• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白淀粉样变心肌病中的左心室流出道梗阻:一例关于诊断、治疗挑战及酒精间隔消融作用的病例报告

Left ventricular outflow tract obstruction in transthyretin amyloid cardiomyopathy: a case report on diagnostic and treatment challenges and role of alcohol septal ablation.

作者信息

Mejren Ali Hussein Jaber, Fensman Sie Kronborg, Poulsen Steen Hvitfeldt

机构信息

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N 8200, Denmark.

出版信息

Eur Heart J Case Rep. 2025 May 12;9(5):ytaf233. doi: 10.1093/ehjcr/ytaf233. eCollection 2025 May.

DOI:10.1093/ehjcr/ytaf233
PMID:40416882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12100115/
Abstract

BACKGROUND

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a restrictive cardiomyopathy caused by amyloid deposition in the myocardium. Its phenotypical overlap with hypertrophic cardiomyopathy, particularly in cases involving left ventricular outflow tract obstruction (LVOTO), challenges accurate diagnosis. Medical management of LVOTO in ATTR-CM is challenged by the opposing effects of beta-blockers and diuretics.

CASE SUMMARY

A 79-year-old male with left ventricular hypertrophy and LVOTO presented with worsening dyspnoea. Full diagnostic work-up confirmed wild-type ATTR-CM. A conservative medical approach with diuretics and beta-blockers proved challenging. Alcohol septal ablation was successfully performed without major complication, resolving the LVOTO and improving symptoms.

DISCUSSION

The diagnosis and management of ATTR-CM with LVOTO are complex. A thorough diagnostic approach is needed to avoid mismanagement. Diuretics and beta-blockers must be carefully balanced to achieve optimal clinical results. Alcohol septal ablation may be considered in patients with persistent symptoms and high LVOT gradients despite optimal medical therapy.

摘要

背景

转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)是一种由淀粉样物质沉积于心肌引起的限制性心肌病。它与肥厚型心肌病在表型上存在重叠,尤其是在涉及左心室流出道梗阻(LVOTO)的病例中,这对准确诊断构成挑战。在ATTR-CM中,LVOTO的药物治疗受到β受体阻滞剂和利尿剂相反作用的影响。

病例摘要

一名患有左心室肥厚和LVOTO的79岁男性出现呼吸困难加重。全面的诊断检查确诊为野生型ATTR-CM。事实证明,使用利尿剂和β受体阻滞剂的保守药物治疗方法具有挑战性。成功进行了酒精间隔消融术,无重大并发症,解除了LVOTO并改善了症状。

讨论

伴有LVOTO的ATTR-CM的诊断和治疗很复杂。需要采用全面的诊断方法以避免管理不当。必须仔细平衡利尿剂和β受体阻滞剂以取得最佳临床效果。对于尽管接受了最佳药物治疗仍有持续症状和高LVOT梯度的患者,可考虑进行酒精间隔消融术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/1817709806f6/ytaf233f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/a156932151ec/ytaf233il2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/a355c71c8154/ytaf233f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/aafc70283d14/ytaf233f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/1817709806f6/ytaf233f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/a156932151ec/ytaf233il2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/a355c71c8154/ytaf233f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/aafc70283d14/ytaf233f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82d1/12100115/1817709806f6/ytaf233f3.jpg

相似文献

1
Left ventricular outflow tract obstruction in transthyretin amyloid cardiomyopathy: a case report on diagnostic and treatment challenges and role of alcohol septal ablation.转甲状腺素蛋白淀粉样变心肌病中的左心室流出道梗阻:一例关于诊断、治疗挑战及酒精间隔消融作用的病例报告
Eur Heart J Case Rep. 2025 May 12;9(5):ytaf233. doi: 10.1093/ehjcr/ytaf233. eCollection 2025 May.
2
Variant cardiac transthyretin amyloidosis presenting as hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: a case report.表现为肥厚型心肌病伴左心室流出道梗阻的变异型心脏转甲状腺素蛋白淀粉样变性:一例报告
Eur Heart J Case Rep. 2025 Jan 23;9(2):ytaf029. doi: 10.1093/ehjcr/ytaf029. eCollection 2025 Feb.
3
Alcohol septal ablation markedly reduces energy loss in hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: A four-dimensional flow cardiac magnetic resonance study.酒精间隔消融术显著降低肥厚型心肌病伴左心室流出道梗阻的能量损失:一项四维血流心脏磁共振研究。
Int J Cardiol Heart Vasc. 2021 Oct 9;37:100886. doi: 10.1016/j.ijcha.2021.100886. eCollection 2021 Dec.
4
Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy.酒精间隔消融术治疗肥厚型梗阻性心肌病
Interv Cardiol. 2014 Apr;9(2):108-114. doi: 10.15420/icr.2011.9.2.108.
5
Complex management of Fabry cardiomyopathy: a case report on the use of alcohol septal ablation and chaperone therapy.法布里心肌病的复杂管理:关于酒精室间隔消融和伴侣疗法应用的病例报告
Eur Heart J Case Rep. 2024 Jul 8;8(7):ytae317. doi: 10.1093/ehjcr/ytae317. eCollection 2024 Jul.
6
Usefulness of Alcohol Septal Ablation in the Left Ventricular Outflow Tract Obstruction in Fabry Disease Cardiomyopathy.酒精室间隔消融术在法布瑞氏病心肌病左心室流出道梗阻中的作用。
Am J Cardiol. 2021 Jul 1;150:110-113. doi: 10.1016/j.amjcard.2021.03.042. Epub 2021 May 16.
7
Long mitral valve leaflets determine left ventricular outflow tract obstruction during exercise in hypertrophic cardiomyopathy.在肥厚型心肌病中,二尖瓣叶冗长决定运动时左心室流出道梗阻情况。
Int J Cardiol. 2016 Jun 1;212:47-53. doi: 10.1016/j.ijcard.2016.03.041. Epub 2016 Mar 16.
8
Two Hearts at Risk: Emergency Alcohol Septal Ablation in a Pregnant Woman With Decompensated HOCM.两颗心脏面临风险:一名失代偿性肥厚型梗阻性心肌病孕妇的紧急酒精间隔消融术
JACC Case Rep. 2020 Jan 15;2(1):139-144. doi: 10.1016/j.jaccas.2019.11.053. eCollection 2020 Jan.
9
[Left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy treated with percutaneous alcohol septal ablation: an echocardiographic study].经皮酒精室间隔消融治疗肥厚性梗阻性心肌病患者的左心室重构:一项超声心动图研究
Rev Esp Cardiol. 2003 Dec;56(12):1174-81. doi: 10.1016/s0300-8932(03)77035-3.
10
Outcomes of Alcohol Septal Ablation in Patients With Severe Left Ventricular Outflow Tract Obstruction: A Propensity Score Matching Analysis.酒精室间隔消融术治疗严重左心室流出道梗阻患者的疗效:倾向评分匹配分析。
Can J Cardiol. 2023 Nov;39(11):1622-1629. doi: 10.1016/j.cjca.2023.06.417. Epub 2023 Jun 22.

本文引用的文献

1
Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild-Type Transthyretin Amyloid Cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病疾病阶段的运动血液动力学和线粒体氧化能力。
J Am Heart Assoc. 2024 Jul 2;13(13):e034213. doi: 10.1161/JAHA.124.034213. Epub 2024 Jun 27.
2
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
3
Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis.
99mTc-DPD骨闪烁显像与转甲状腺素蛋白淀粉样变心肌病患者组织学淀粉样蛋白负荷的相关性
Amyloid. 2024 Mar;31(1):22-31. doi: 10.1080/13506129.2023.2239986. Epub 2023 Aug 2.
4
Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient.心脏淀粉样变的相对心尖保留并不总是由淀粉样变梯度解释。
Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1258-1268. doi: 10.1093/ehjci/jead107.
5
Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure-Barriers and Opportunities for Improvement: The PREVAMIC Study.评估老年心力衰竭患者心脏淀粉样变性的患病率——改善的障碍与机遇:PREVAMIC研究
J Clin Med. 2023 Mar 15;12(6):2273. doi: 10.3390/jcm12062273.
6
Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy.酒精室间隔消融术治疗心脏淀粉样变性所致左心室流出道梗阻:一种既定疗法的新适应证。
Catheter Cardiovasc Interv. 2022 Nov;100(5):910-914. doi: 10.1002/ccd.30411. Epub 2022 Sep 24.
7
Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy.随机试验米索洛尔治疗梗阻性肥厚型心肌病患者。
J Am Coll Cardiol. 2021 Dec 21;78(25):2505-2517. doi: 10.1016/j.jacc.2021.07.065.
8
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.心脏淀粉样变性的诊断与治疗:欧洲心脏病学会心肌与心包疾病工作组的立场声明
Eur Heart J. 2021 Apr 21;42(16):1554-1568. doi: 10.1093/eurheartj/ehab072.
9
Reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update.成人和儿童心血管磁共振(CMR)的参考范围(“正常值”):2020 更新。
J Cardiovasc Magn Reson. 2020 Dec 14;22(1):87. doi: 10.1186/s12968-020-00683-3.
10
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy.在因初始诊断为肥厚型心肌病而被转诊至三级中心的成年患者中,心脏淀粉样变性的患病率。
Int J Cardiol. 2020 Feb 1;300:191-195. doi: 10.1016/j.ijcard.2019.07.051. Epub 2019 Jul 17.